Valcare Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
34

- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Valcare General Information
Description
Developer of a transcatheter technology designed to offer treatment for mitral and tricuspid regurgitation. The company's technology serves as a docking station for replacement prostheses and a tool for mitral annulus repair, enabling patients with heart disorders to get advanced treatment and recover faster.
Contact Information
Website
www.valcaremedical.comCorporate Office
- PO Box 12268
- Maskit 2, Herzlyia Pituach
- Herzliya 4673301
- Israel
Corporate Office
- PO Box 12268
- Maskit 2, Herzlyia Pituach
- Herzliya 4673301
- Israel
Valcare Timeline
Valcare Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Secondary Transaction - Private | 01-Aug-2023 | Completed | Generating Revenue | |||
6. Later Stage VC | 28-Jul-2022 | Completed | Generating Revenue | |||
5. Later Stage VC (Series D) | 22-Jul-2021 | Completed | Generating Revenue | |||
4. Later Stage VC (Series D) | 01-Sep-2018 | Completed | Generating Revenue | |||
3. Later Stage VC (Series C) | 19-Jun-2017 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A) | 29-Jun-2012 | $8M | $14M | Completed | Startup | |
1. Early Stage VC | $6M | $6M | Completed | Startup |
Valcare Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D | ||||||||
Series C | ||||||||
Series B | 4,111,000 | $0.000100 | 6% | $1.46 | $1.46 | 1x | $0.32 | 7.97% |
Series A | 6,667,731 | $0.000100 | 6% | $1.46 | $1.46 | 1x | $0.32 | 12.92% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Valcare Comparisons
Industry
Financing
Details
Valcare Competitors (20)
One of Valcare’s 20 competitors is JenaValve Technology, a Pending Transaction (M&A) company based in Irvine, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
JenaValve Technology | Pending Transaction (M&A) | Irvine, CA | ||||
InnovHeart | Venture Capital-Backed | Milan, Italy | ||||
MitrAssist | Private Equity-Backed | Caesarea, Israel | ||||
Coramaze Technologies | Venture Capital-Backed | Tel Aviv, Israel | ||||
HighLife | Venture Capital-Backed | Paris, France |
Valcare Patents
Valcare Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230372086-A1 | Systems and methods preventing paravalvular leak (pvl) associated with a replacement structural cardiac valve | Pending | 23-May-2022 | ||
EP-3982844-A1 | Systems and methods for delivery of chordae replacement system | Inactive | 11-Jun-2019 | ||
EP-3982844-A4 | Systems and methods for delivery of chordae replacement system | Inactive | 11-Jun-2019 | ||
EP-3525864-B1 | Device for delivery of an implant through a catheter | Active | 11-Oct-2016 | ||
EP-3525864-A4 | Device and method for delivery of an implant through a catheter | Active | 11-Oct-2016 | A61F2/2436 |
Valcare Signals
Valcare Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Techwald Holding | Venture Capital | Minority | ||
BioStar Capital | Venture Capital | Minority | ||
HBM Partners | Venture Capital | Minority | ||
MicroPort CardioFlow | Corporation | Minority | ||
Arkin Capital | Venture Capital | Minority |
Valcare FAQs
-
When was Valcare founded?
Valcare was founded in 2012.
-
Where is Valcare headquartered?
Valcare is headquartered in Herzliya, Israel.
-
What is the size of Valcare?
Valcare has 34 total employees.
-
What industry is Valcare in?
Valcare’s primary industry is Therapeutic Devices.
-
Is Valcare a private or public company?
Valcare is a Private company.
-
What is Valcare’s current revenue?
The current revenue for Valcare is
. -
How much funding has Valcare raised over time?
Valcare has raised $44.3M.
-
Who are Valcare’s investors?
Techwald Holding, BioStar Capital, HBM Partners, MicroPort CardioFlow, and Arkin Capital are 5 of 6 investors who have invested in Valcare.
-
Who are Valcare’s competitors?
JenaValve Technology, InnovHeart, MitrAssist, Coramaze Technologies, and HighLife are some of the 20 competitors of Valcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »